Literature DB >> 15082766

Nucleophosmin sets a threshold for p53 response to UV radiation.

Dony A Maiguel1, Leslie Jones, Devulapalli Chakravarty, Chonglin Yang, France Carrier.   

Abstract

Because activation of p53 can trigger cell cycle arrest and apoptosis, it is necessary for a cell to suppress this activation until it is absolutely required for survival. The mechanisms underlying this important regulatory event are poorly understood. Here we show that nucleophosmin (NPM) acts as a natural repressor of p53 by setting a threshold for p53 activation in response to UV radiation. NPM binds to the p53 N terminus and inhibits p53 transcriptional activity by more than 70%. Our data indicate that the levels of NPM in a cell determine the UV dose at which the tumor suppressor p53 can be phosphorylated on Ser15. Moreover, we show that NPM is a substrate for the UV-activated protein kinase ATR and inhibits the UV-induced p53 phosphorylation at Ser15. In addition, NPM forms a complex with p53 and ATR in vivo. These data suggest that NPM is an early responder to DNA damage that prevents premature activation of p53. In normal cells, NPM could contribute to suppressing p53 activation until its functions are absolutely required while in cancer cells overexpression of NPM could contribute to p53 inactivation and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082766      PMCID: PMC387774          DOI: 10.1128/MCB.24.9.3703-3711.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity.

Authors:  T Kondo; N Minamino; T Nagamura-Inoue; M Matsumoto; T Taniguchi; N Tanaka
Journal:  Oncogene       Date:  1997-09       Impact factor: 9.867

2.  Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression.

Authors:  Ming H Wu; Jei H Chang; Benjamin Y M Yung
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

3.  Oncogenic forms of p53 inhibit p53-regulated gene expression.

Authors:  S E Kern; J A Pietenpol; S Thiagalingam; A Seymour; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

4.  Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth.

Authors:  W Y Chan; Q R Liu; J Borjigin; H Busch; O M Rennert; L A Tease; P K Chan
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

5.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

6.  The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells.

Authors:  M D Todd; M J Lee; J L Williams; J M Nalezny; P Gee; M B Benjamin; S B Farr
Journal:  Fundam Appl Toxicol       Date:  1995-11

7.  DNA damage induces phosphorylation of the amino terminus of p53.

Authors:  J D Siliciano; C E Canman; Y Taya; K Sakaguchi; E Appella; M B Kastan
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

8.  Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation.

Authors:  M Kapoor; G Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

9.  Amino acid sequence of protein B23 phosphorylation site.

Authors:  P K Chan; M Aldrich; R G Cook; H Busch
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

10.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

View more
  32 in total

1.  Long-term evolution and functional diversification in the members of the nucleophosmin/nucleoplasmin family of nuclear chaperones.

Authors:  José M Eirín-López; Lindsay J Frehlick; Juan Ausió
Journal:  Genetics       Date:  2006-06-04       Impact factor: 4.562

2.  The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress.

Authors:  Narasimharao Nalabothula; Fred E Indig; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

3.  Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.

Authors:  Narasimharao Nalabothula; Devulapalli Chakravarty; Adam Pierce; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

Review 4.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

5.  Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.

Authors:  June Li; Daniel P Sejas; Sandeep Burma; David J Chen; Qishen Pang
Journal:  Carcinogenesis       Date:  2007-02-02       Impact factor: 4.944

6.  MKK7 and ARF: new players in the DNA damage response scenery.

Authors:  Athanassios Kotsinas; Panagiota Papanagnou; Panagiotis Galanos; Daniel Schramek; Paul Townsend; Josef M Penninger; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Cell Cycle       Date:  2014-03-26       Impact factor: 4.534

7.  Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non-Small Cell Lung Cancer.

Authors:  Fei Li; Wai-Lung Ng; Troy A Luster; Hai Hu; Vladislav O Sviderskiy; Catríona M Dowling; Kate E R Hollinshead; Paula Zouitine; Hua Zhang; Qingyuan Huang; Michela Ranieri; Wei Wang; Zhaoyuan Fang; Ting Chen; Jiehui Deng; Kai Zhao; Hon-Cheong So; Alireza Khodadadi-Jamayran; Mousheng Xu; Angeliki Karatza; Val Pyon; Shuai Li; Yuanwang Pan; Kristen Labbe; Christina Almonte; John T Poirier; George Miller; Richard Possemato; Jun Qi; Kwok-Kin Wong
Journal:  Cancer Res       Date:  2020-07-09       Impact factor: 12.701

8.  The natural product avrainvillamide binds to the oncoprotein nucleophosmin.

Authors:  Jeremy E Wulff; Romain Siegrist; Andrew G Myers
Journal:  J Am Chem Soc       Date:  2007-10-25       Impact factor: 15.419

9.  NPM phosphorylation stimulates Cdk1, overrides G2/M checkpoint and increases leukemic blasts in mice.

Authors:  Wei Du; Yun Zhou; Suzette Pike; Qishen Pang
Journal:  Carcinogenesis       Date:  2009-11-23       Impact factor: 4.944

10.  TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice.

Authors:  Yun Zhou; Wei Du; Tara Koretsky; Grover C Bagby; Qishen Pang
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.